News
Get ready for the 3rd International LAMA2-CMD Conference – And we need your help!
The third International LAMA2-CMD Conference is set for March 2026 in Turkey, and we need the voices of patients and…
The knowledge base
-
![]()
News
-
![]()
Personal stories
From patient to researcher: Justin Moy’s fight against LAMA2-CMD
This is a summarized version of an original article published by Boston University. Read the full article here. For Justin…
-
![]()
News
Markus Rüegg’s mission: Developing a gene therapy for LAMA2-CMD
This article is a translated and summarized version of an original German interview with Professor Markus Rüegg Hope for a…
-
![]()
News
A look back on a conference to shape LAMA2 clinical care guidelines
We are delighted to reflect on the success of the ENMC conference, initiated by Voor Sara and Cure CMD. Together,…
-
![]()
News
Help shape the future of LAMA2-Related Dystrophy care guidelines
In January 2025, clinicians specialising in LAMA2-Congenital Muscular Dystrophy (LAMA2-CMD) will convene in The Netherlands to begin developing updated care…
-
![]()
News
Modalis Therapeutics receives FDA Orphan Drug designation
Modalis Therapeutics has been granted U.S. FDA’s grant of Orphan Drug Designation (ODD) for MDL-101, a cutting-edge treatment for congenital…
The driving forces behind Lama2.com
Bekijk alle partners
